Prezzo di RosecoinROSE

Yahoo Finance Yahoo Finance Sign in Search query Search for news or symbols Simply Wall St. November 10, 2024 3 min read In This Article: GOSS -9.97% Find Online Jobs In USA - Earn Up To $1500 Monthly Online Jobs In USA | Search Ads Ad As you might know, Gossamer Bio, Inc. (NASDAQ:GOSS) just kicked off its latest quarterly results with some very strong numbers. Results clearly exceeded expectations, with a substantial revenue beat leading to smaller losses in what looks like a definite win for investors. Revenues were US$9.5m and the statutory loss per share was US$0.14, smaller than the analysts had forecast. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Gossamer Bio after the latest results.Taking into account the latest results, the current consensus, from the eight analysts covering Gossamer Bio, is for revenues of US$18.7m in 2025. This implies a stressful 82% reduction in Gossamer Bio's revenue over the past 12 months. Losses are forecast to balloon 121% to US$0.70 per share. Yet prior to the latest earnings, the analysts had been forecasting revenues of US$18.6m and losses of US$0.72 per share in 2025. So there seems to have been a moderate uplift in analyst sentiment with the latest consensus release, given the upgrade to loss per share forecasts for next year. The average price target rose 17% to US$6.72, with the analysts signalling that the forecast reduction in losses would be a positive for the stock's valuation. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. There are some variant perceptions on Gossamer Bio, with the most bullish analyst valuing it at US$15.00 and the most bearish at US$0.50 per share. With such a wide range in price targets, analysts are almost certainly betting on widely divergent outcomes in the underlying business. With this in mind, we wouldn't rely too heavily the consensus price target, as it is just an average and analysts clearly have some deeply divergent views on the business. Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. We would highlight that revenue is expected to reverse, with a forecast 75% annualised decline to the end of 2025. That is a notable change from historical growth of 104% over the last five years. By contrast, our data suggests that other companies (with analyst coverage) in the same industry are forecast to see their revenue grow 21% annually for the foreseeable future. It's pretty clear that Gossamer Bio's revenues are expected to perform substantially worse than the wider industry.

Yahoo Finance Yahoo Finance Sign in Search query Search for news or symbols Simply Wall St. Gossamer Bio, Inc. (NASDAQ:GOSS) Just Reported And Analysts Have Been Lifting Their Price Targets editorial-team@simplywallst.com (Simply Wall St) November 10, 2024 3 min read In This Article: GOSS -9.97% Find Online Jobs In USA - Earn Up To $1500 Monthly Online Jobs In USA | Search Ads Ad As you might know, Gossamer Bio, Inc. (NASDAQ:GOSS) just kicked off its latest quarterly results with some very strong numbers. Results clearly exceeded expectations, with a substantial revenue beat leading to smaller losses in what looks like a definite win for investors. Revenues were US$9.5m and the statutory loss per share was US$0.14, smaller than the analysts had forecast. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Gossamer Bio after the latest results.Taking into account the latest results, the current consensus, from the eight analysts covering Gossamer Bio, is for revenues of US$18.7m in 2025. This implies a stressful 82% reduction in Gossamer Bio's revenue over the past 12 months. Losses are forecast to balloon 121% to US$0.70 per share. Yet prior to the latest earnings, the analysts had been forecasting revenues of US$18.6m and losses of US$0.72 per share in 2025. So there seems to have been a moderate uplift in analyst sentiment with the latest consensus release, given the upgrade to loss per share forecasts for next year. The average price target rose 17% to US$6.72, with the analysts signalling that the forecast reduction in losses would be a positive for the stock's valuation. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. There are some variant perceptions on Gossamer Bio, with the most bullish analyst valuing it at US$15.00 and the most bearish at US$0.50 per share. With such a wide range in price targets, analysts are almost certainly betting on widely divergent outcomes in the underlying business. With this in mind, we wouldn't rely too heavily the consensus price target, as it is just an average and analysts clearly have some deeply divergent views on the business. Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. We would highlight that revenue is expected to reverse, with a forecast 75% annualised decline to the end of 2025. That is a notable change from historical growth of 104% over the last five years. By contrast, our data suggests that other companies (with analyst coverage) in the same industry are forecast to see their revenue grow 21% annually for the foreseeable future. It's pretty clear that Gossamer Bio's revenues are expected to perform substantially worse than the wider industry.

Crypto Market Crash (Jan 8th, 2025): Bitcoin Price Drops to $96k | Millions Wiped Out from Market! Fear & Greed Index drops to 54, highlighting a neutral investor sentiment. Global crypto market capitalization slips 6.12% to $3.36T. B,g emerges as the sole gainer among the top 100 cryptos The cryptocurrency market experienced a sharp downturn today, with the global market cap shedding 6.12%, plunging to $3.36 trillion. A steep increase in trading volume, up 35.28% to $172.39 billion, reflects growing market activity despite volatility. The Fear & Greed Index dropped to 54, signaling a neutral sentiment as traders navigate uncertainty. Key Factors Fueling the Crash A sharp rise in U.S. Treasury yields over the past decade, coupled with macroeconomic uncertainties such as fiscal deficits and a looming debt ceiling, has driven investor unease. These factors have increased volatility across asset classes, impacting cryptocurrencies. Bitcoin Price Today Bears the Brunt? Bitcoin, the market leader, saw its price decline by 5.23% over the past 24 hours, settling at $96,418.88. Despite the drop, its market cap remains robust at $1.91 trillion. Trading volume for BTC rose significantly by 26.81% to $62.56 billion, reflecting increased sell-side pressure amid macroeconomic headwinds. Explore more in-depth Bitcoin insights in our Bitcoin Price Prediction. Altcoins Back in Turmoil? Ethereum led the altcoin market fall with a steep 8.61% drop to $3,352.49. Solana and XRP followed, falling 9.21% and 5.06%, respectively. The broader market sentiment reflects unease, as traders weigh the potential impact of external factors on crypto valuations.

Sonic SVM's token generation event, which took place yesterday, January 7, 2025, marked a significant milestone for the project. As part of this event, players of SonicX, a popular TikTok-based tap-to-earn game, received airdropped tokens for their in-app progress ¹. Sonic SVM is a layer-2 gaming chain built on Solana, a blockchain platform known for its fast transaction times and low fees. This strategic decision sets Sonic SVM apart from other gaming platforms, which often launch on The Open Network (TON) or Telegram ¹. The $SONIC token will play a crucial role in the Sonic SVM ecosystem, with various use cases, including: - *Payment Currency*: $SONIC will be used for transactions within the ecosystem. - *Staking Rewards*: Token holders will be incentivized with staking rewards. - *Governance Voting*: $SONIC holders will have a say in the project's decision-making process ². With a total supply of 2.4 billion $SONIC tokens, the project is poised for significant growth and adoption in the coming months ². SonicX, the tap-to-earn game, has been gaining popularity since its launch in October, and its success is part of a larger trend of tap-to-earn games that rose to popularity in 2024 ¹.

Crypto Market Crash (Jan 8th, 2025): Bitcoin Price Drops to $96k | Millions Wiped Out from Market! Fear & Greed Index drops to 54, highlighting a neutral investor sentiment. Global crypto market capitalization slips 6.12% to $3.36T. B,g emerges as the sole gainer among the top 100 cryptos The cryptocurrency market experienced a sharp downturn today, with the global market cap shedding 6.12%, plunging to $3.36 trillion. A steep increase in trading volume, up 35.28% to $172.39 billion, reflects growing market activity despite volatility. The Fear & Greed Index dropped to 54, signaling a neutral sentiment as traders navigate uncertainty. Key Factors Fueling the Crash A sharp rise in U.S. Treasury yields over the past decade, coupled with macroeconomic uncertainties such as fiscal deficits and a looming debt ceiling, has driven investor unease. These factors have increased volatility across asset classes, impacting cryptocurrencies. Bitcoin Price Today Bears the Brunt? Bitcoin, the market leader, saw its price decline by 5.23% over the past 24 hours, settling at $96,418.88. Despite the drop, its market cap remains robust at $1.91 trillion. Trading volume for BTC rose significantly by 26.81% to $62.56 billion, reflecting increased sell-side pressure amid macroeconomic headwinds. Explore more in-depth Bitcoin insights in our Bitcoin Price Prediction. Altcoins Back in Turmoil? Ethereum led the altcoin market fall with a steep 8.61% drop to $3,352.49. Solana and XRP followed, falling 9.21% and 5.06%, respectively. The broader market sentiment reflects unease, as traders weigh the potential impact of external factors on crypto valuations.